Related Experiment Videos
Mode of interaction between platelet factor 4 and heparin
1Department of Medical and Physiological Chemistry, University of Uppsala, Sweden.
Glycobiology
|June 1, 1993
Summary
Platelet factor 4 (PF4) binds heparin through non-specific electrostatic interactions, unlike antithrombin (AT). This study clarifies PF4
Area of Science:
- Biochemistry
- Molecular Biology
- Glycobiology
Background:
- Platelet factor 4 (PF4) neutralizes heparin and heparan sulfate biological activities.
- Understanding PF4-heparin interactions is crucial for various biological processes.
Purpose of the Study:
- To investigate the binding mode of PF4 to heparin.
- To compare PF4 binding with antithrombin (AT) and fibronectin (FN) interactions.
- To determine the specificity of PF4-heparin binding.
Main Methods:
- Comparative study of PF4, AT, and FN binding to heparin-derived oligosaccharides.
- Incubation of saccharides with proteins followed by nitrocellulose filter separation.
- Analysis using 3H-labelled heparin and size-fractionated oligosaccharides.
- Anion-exchange chromatography to assess binding specificity and charge dependency.
Main Results:
- PF4 and FN binding to heparin increased with oligosaccharide size.
- PF4- and FN-binding oligosaccharides correlated with charge and degree of sulfation.
- AT binding was selective for specific oligosaccharide components, independent of overall charge.
- PF4-heparin interaction demonstrated non-specific electrostatic binding.
Conclusions:
- PF4 binds heparin via relatively non-specific electrostatic interactions.
- Oligosaccharide size and charge are key factors in PF4-heparin binding.
- The methodology can assess specificity in glycosaminoglycan-protein interactions.